Protective effect of amifostine against toxicity of paclitaxel and carboplatin in non-small cell lung cancer - A single center randomized study

Kanat, O; Evrensel, TÜRKKAN; Baran, I; Coskun, H; Zarifoglu, M; Turan, OF; Kurt, E; Demiray, M; Gonullu, G; Manavoglu, O

doi:10.1385/mo:20:3:237

Protective effect of amifostine against toxicity of paclitaxel and carboplatin in non-small cell lung cancer - A single center randomized study

Kanat O., Evrensel T., Baran I., Coskun H., Zarifoglu M., Turan O., ...Daha Fazla

MEDICAL ONCOLOGY, cilt.20, sa.3, ss.237-245, 2003 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 20 Sayı: 3
Basım Tarihi: 2003
Doi Numarası: 10.1385/mo:20:3:237
Dergi Adı: MEDICAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.237-245
Anahtar Kelimeler: amifostine, paclitaxel, carboplatin, CISPLATIN PLUS VINORELBINE, PHASE-II, TRIAL, COMBINATION, INFUSION, 1-HOUR, DAMAGE, AGENT, HEAD
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Aim: In this study we determined the protective role of amifostine against the side effects of the combination of paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC).